cbdMD YCBD Stock Why It Could Surge Ticks Down 20260416 The steady strength in Entergy ENJ story Overhead Buying 20260507 Intellia Therapeutics NTLA beats Q4 estimates as revenue climbs 169 percent annually shares rise 277 percent Seres Therapeutics MCRB Declines 218 as Stock Approaches Key Support